RU2017104233A3 - - Google Patents

Download PDF

Info

Publication number
RU2017104233A3
RU2017104233A3 RU2017104233A RU2017104233A RU2017104233A3 RU 2017104233 A3 RU2017104233 A3 RU 2017104233A3 RU 2017104233 A RU2017104233 A RU 2017104233A RU 2017104233 A RU2017104233 A RU 2017104233A RU 2017104233 A3 RU2017104233 A3 RU 2017104233A3
Authority
RU
Russia
Application number
RU2017104233A
Other versions
RU2017104233A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/329,023 external-priority patent/US20160008310A1/en
Priority claimed from EP14176821.8A external-priority patent/EP2965750B1/en
Application filed filed Critical
Publication of RU2017104233A publication Critical patent/RU2017104233A/ru
Publication of RU2017104233A3 publication Critical patent/RU2017104233A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
RU2017104233A 2014-07-11 2015-07-10 Диспергируемая таблетка мизопростола RU2017104233A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14176821.8 2014-07-11
US14/329,023 2014-07-11
US14/329,023 US20160008310A1 (en) 2014-07-11 2014-07-11 Misoprostol dispersible tablet
EP14176821.8A EP2965750B1 (en) 2014-07-11 2014-07-11 Misoprostol dispersible tablet
PCT/DK2015/050216 WO2016004960A2 (en) 2014-07-11 2015-07-10 Misoprostol dispersible tablet

Publications (2)

Publication Number Publication Date
RU2017104233A RU2017104233A (ru) 2018-08-13
RU2017104233A3 true RU2017104233A3 (ru) 2018-12-18

Family

ID=53879283

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017104233A RU2017104233A (ru) 2014-07-11 2015-07-10 Диспергируемая таблетка мизопростола

Country Status (12)

Country Link
US (2) US11406615B2 (ru)
EP (1) EP3166597A2 (ru)
JP (2) JP6532529B2 (ru)
AU (1) AU2015287186B2 (ru)
BR (1) BR112017000529A2 (ru)
CA (1) CA2954086C (ru)
EA (1) EA039069B1 (ru)
MX (1) MX2017000399A (ru)
NZ (1) NZ727876A (ru)
RU (1) RU2017104233A (ru)
TN (1) TN2017000003A1 (ru)
WO (1) WO2016004960A2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108434110B (zh) * 2018-04-28 2019-09-10 浙江仙琚制药股份有限公司 米索前列醇组合物、片剂及其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9419566D0 (en) * 1994-09-27 1994-11-16 El Refaey Hazem Oral prostagladins for the routine management of the third stage of labour
IL150053A0 (en) * 1999-12-06 2002-12-01 Mendell Co Inc Edward Pharmaceutical superdisintegrant
GB0204771D0 (en) * 2002-02-28 2002-04-17 Phoqus Ltd Fast disintegrating tablets
TW200502000A (en) * 2003-03-28 2005-01-16 Kyowa Hakko Kogyo Kk Dividing tablet
WO2006125450A1 (en) 2005-05-26 2006-11-30 Atef Mohammed Mostafa Darwish Rectal and vaginal suppositories containing misoprostol
US20060286172A1 (en) 2005-06-03 2006-12-21 Anu Mahashabde Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same
WO2007052289A2 (en) * 2005-07-22 2007-05-10 Rubicon Research Pvt Ltd. Novel dispersible tablet composition
US8148560B2 (en) * 2005-09-23 2012-04-03 Teva Women's Health, Inc. Vaginal tablets comprising misoprostol and methods of making and using the same
US7799530B2 (en) 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
KR101626873B1 (ko) * 2007-10-01 2016-06-02 라보라토리오스 레스비, 에스.엘. 구강붕해정제
WO2009154810A2 (en) * 2008-02-25 2009-12-23 Dr. Reddy's Laboratories Ltd. Delivery systems for multiple active agents
CN102697746B (zh) * 2012-06-11 2014-03-19 广州朗圣药业有限公司 一种快速融变的米索前列醇阴道用组合物及其制备方法和应用
WO2014016394A1 (en) 2012-07-26 2014-01-30 Ferring B.V. Misprostol composition
CN102872024B (zh) * 2012-09-28 2015-06-17 天津市聚星康华医药科技有限公司 口腔内使用的米索前列醇药物组合物
CN103340837B (zh) * 2013-07-08 2018-04-27 天津市聚星康华医药科技有限公司 一种米索前列醇阴道泡腾片及其制备方法

Also Published As

Publication number Publication date
JP6921894B2 (ja) 2021-08-18
AU2015287186B2 (en) 2018-05-31
US20210322356A1 (en) 2021-10-21
CA2954086A1 (en) 2016-01-14
AU2015287186A1 (en) 2017-01-19
NZ727876A (en) 2018-05-25
TN2017000003A1 (en) 2018-07-04
WO2016004960A2 (en) 2016-01-14
EA039069B1 (ru) 2021-11-30
BR112017000529A2 (pt) 2017-11-14
JP2017520628A (ja) 2017-07-27
CA2954086C (en) 2020-03-31
JP2019147831A (ja) 2019-09-05
EP3166597A2 (en) 2017-05-17
MX2017000399A (es) 2017-08-10
JP6532529B2 (ja) 2019-06-19
WO2016004960A3 (en) 2016-03-17
US20220347145A1 (en) 2022-11-03
EA201692536A1 (ru) 2017-06-30
RU2017104233A (ru) 2018-08-13
US11406615B2 (en) 2022-08-09

Similar Documents

Publication Publication Date Title
BR112016019526A2 (ru)
BR112016019684A2 (ru)
BR112016021201A2 (ru)
BR112016020269A2 (ru)
BR112016020808A2 (ru)
BR112016017713A2 (ru)
BR112016023035A2 (ru)
BR112016022204A2 (ru)
BR112016030436A2 (ru)
BR112016018137A2 (ru)
BR112016027311A2 (ru)
BR112016023457A2 (ru)
BR112016030299A2 (ru)
BR112016026283A2 (ru)
RU2015124246A3 (ru)
BR112016028013A2 (ru)
BR112016025646A2 (ru)
BR112016030591A2 (ru)
BR112016020147A2 (ru)
BR112016025796A2 (ru)
BR112016018677A2 (ru)
BR112016021832A2 (ru)
JP1518644S (ru)
CN302716077S (ru)
CN302710472S (ru)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20190830